What is Ora?
Ora operates as a dedicated entity focused exclusively on ophthalmic research and product development. With an extensive history spanning over 45 years, the company has cultivated deep expertise, evidenced by its successful execution of more than 3,000 ophthalmic clinical projects. This track record has been instrumental in facilitating the market approval of a substantial number of drugs and devices within the eye care sector, positioning Ora as a key partner for innovation in ophthalmology.
How much funding has Ora raised?
Ora has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Ora
PPP
Public-Private Partnership
What's next for Ora?
The recent major strategic investment signals a period of accelerated growth and potential expansion for Ora. This capital infusion is likely to be directed towards enhancing its research capabilities, expanding its service offerings, and potentially exploring new therapeutic areas within ophthalmology. The company's long-standing experience suggests a strategic approach to leveraging this new financing to further solidify its leadership in clinical research and product development for eye care solutions.
See full Ora company page
